Paynantheine more effectively reverses multidrug resistance in malignant EPG85.257RDB and MCF7MX cells than morphine and speciociliatine
Cell Biology International · 2024
DOI: 10.1002/cbin.12152 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cell Biology International, 2024. Verfasst von Nayereh Abdali und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Biotechnology, School of Advanced Technologies, Shahrekord University of Medical Sciences, Shahrekord, Iran. Hauptthemen laut MEDLINE: Morphine, Drug Resistance, Neoplasm, ATP Binding Cassette Transporter, Subfamily G, Member 2, Drug Resistance, Multiple. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 42 Literaturangaben. Gefördert von: Shahrekord University of Medical Sciences.
Abstract (Originalsprache)
The possible interactions of morphine, paynantheine and speciociliatine alkaloids with ATP‐binding cassette (ABC) transporters was investigated. The compounds were docked against ABCG2 and ABCB1 to predict the binding mode of alkaloids in active binding sites. The cytotoxicity of morphine, paynantheine and speciociliatine for EPG85.257RDB and MCF7MX cells was determined and ABCB1 and ABCG2 gene and protein expression were determined. The binding score of paynantheine to ABCB1 was higher in the docking studies. Paynantheine and speciociliatine had similar binding scores to ABCB1, but higher binding scores to ABCG2 than did morphine. Paynantheine and speciociliatine were more effective against MCF7MX and EPG85.257RDB cells and showed greater cyctotoxicity in the MTT assay. The effect of morphine and paynantheine on the ABCB1 gene and protein expression suggests these compounds can reduce resistance in cancer patients, but that speciociliatine may not be a suitable candidate because of its increased ABCB1 expression while speciociliatine decreased the expression of ABCG2 in MCF7MX cells. This indicates that speciociliatine is a better candidate for reducing drug resistance in this cell line. Structural modification, drug‐metabolizing enzymes and differences in the binding sites could cause functional differences between these compounds.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medical Biotechnology, School of Advanced Technologies, Shahrekord University of Medical Sciences, Shahrekord, Iran.
- Cellular and Molecular Research Center, Basic Health Sciences Institute, Shahrekord University of Medical Sciences, Shahrekord, Iran.
Förderung
- Shahrekord University of Medical Sciences
Zitieren
APA
Abdali, N., Nadipour Borujeni, M., Hosseini, S. A., Malekzadeh, R., Abolhasani, M., Mirzaei, S. A., & Elahian, F. (2024). Paynantheine more effectively reverses multidrug resistance in malignant EPG85.257RDB and MCF7MX cells than morphine and speciociliatine. Cell Biology International. https://doi.org/10.1002/cbin.12152
Vancouver
Abdali N, Nadipour Borujeni M, Hosseini SA, Malekzadeh R, Abolhasani M, Mirzaei SA, et al. Paynantheine more effectively reverses multidrug resistance in malignant EPG85.257RDB and MCF7MX cells than morphine and speciociliatine. Cell Biology International. 2024. doi:10.1002/cbin.12152
BibTeX
@article{Abdali2024,
author = {Abdali, Nayereh and Nadipour Borujeni, Mohammad and Hosseini, Sayedeh Azimeh and Malekzadeh, Rahim and Abolhasani, Marzieh and Mirzaei, Seyed Abbas and Elahian, Fatemeh},
title = {Paynantheine more effectively reverses multidrug resistance in malignant EPG85.257RDB and MCF7MX cells than morphine and speciociliatine},
journal = {Cell Biology International},
year = {2024},
doi = {10.1002/cbin.12152}
}
EUVIMED